Header image

On Demand Topic: HCV Reinfection

Thursday, September 2, 2021
1:00 AM - 2:00 AM

Speaker

Dr Joanne Carson
Infectious disease and data scientist
Kirby Institute, UNSW

#PO57: Real-World Effectiveness Of Retreatment For Reinfection And Virological Failure Among People Who Inject Drugs In The Reach-C Cohort

Abstract PDF

Video / Audio Recordings

Biography

Joanne Carson (BSc MPH) is a PhD candidate and research assistant at the Kirby Institute UNSW Sydney.
Agenda Item Image
Miss Madeleine Caven
Postgraduate Medical Student
University Of Dundee

#VP74: Hepatitis C Reinfection By Treatment Pathway Among People Who Inject Drugs In Tayside, Scotland

Abstract PDF

Speaker Presentation

Video / Audio Recordings

Biography

Madeleine Caven is a postgraduate medical student at the University of St Andrews and University of Dundee. Madeleine has a background in Psychology and Hepatitis C research, with interests in healthcare accessibility, public health research, and realistic medicine.
Agenda Item Image
MD Brian Conway
Medical Director and President
Vancouver Infectious Diseases Centre

#VP75: Long-Term Evaluation Of HCV Re-Infection Rates Among Inner City Vulnerable Populations

Abstract PDF

Video / Audio Recordings

Biography

Brian Conway is an infectious diseases physician specializing in the design and evaluation of novel models of care for the treatment of HCV infection in vulnerable populations. He has collaborated with researchers on national and international levels on clinical trials and published extensively on his real-life experiences in this field.
Agenda Item Image
Dr Sarah Kattakuzhy
Associate Professor
Institute of Human Virology at the University of Maryland School of Medicine

#VP76: High Rates Of HCV Reinfection And Retreatment In A Cohort Of PWID With HCV Cure: 3.5 Year Follow Up Data From The Anchor Cohort

Abstract PDF

Speaker Presentation

Video / Audio Recordings

Biography

Dr. Kattakuzhy is an Assistant Professor at the Institute of Human Virology at the University of Maryland School of Medicine in Baltimore. She serves as the Co-Director of the Research Initiative on Infectious Diseases in Substance Use. Her research utilizes implementation science to improve care in marginalized populations.
Agenda Item Image
Dr Amy McEwan
Graduate Teaching Assistant
University of Glasgow

#PO58: Hepatitis C Reinfection In The Direct-Acting Antiviral Era: A Scoping Review

Abstract PDF

Speaker Presentation

Video / Audio Recordings

Biography

Amy K. McEwan is a second year PhD student at Glasgow Caledonian University in Scotland. Her PhD topic focuses on Hepatitis C reinfection amongst people who inject drugs in the direct-acting antiviral era.
Agenda Item Image
Dr Håvard Midgard
senior consultant / associate professor
Oslo University Hospital

#VP77: Hepatitis C Treatment And Reinfection Surveillance Among People Who Inject Drugs In A Low-Threshold Program In Oslo, Norway

Abstract PDF

Speaker Presentation

Video / Audio Recordings

Biography

Håvard Midgard is a specialist in gastroenterology and postdoctoral researcher at Oslo University Hospital and Akershus University Hospital. His research interests include HCV epidemiology, models of care, and general hepatology. He is a founding member of the Norwegian Center for HCV elimination and a former INHSU board member.
Agenda Item Image
Ms Mercy Nyakowa
HCV Testing & Treatment coordinator
National AIDs and STI Control Program ,Ministry of Health Kenya

#VP78: Low Hepatitis C Virus Reinfection In People Who Inject Drugs Treated With Direct Acting Antivirals In Kenya

Abstract PDF

Biography

Postdoctoral Research Fellow at Boston Medical Center, focusing on addiction medicine. Her research focuses on marginalized populations in global health, behavioral health, and epidemiology. As a doctoral student, she was principal investigator of a study conducted in partnership with the MOH in Kenya to assess HCV reinfection among PWID.
Ms Verónica Saludes
Postdoc Researcher
Germans Trias I Pujol Research Institute (igtp)

#VP79: HCV Reinfection Is Common In People Entering Prisons In Catalonia, Spain (Re-HCV Study)

Abstract PDF

Speaker Presentation

Video / Audio Recordings

Biography

Postdoc Researcher at the Clinical Virology and New Diagnostic Tools Group led by Elisa Martró. Their activity focuses on improving the diagnosis of active HCV and HBV infection among key populations at risk of infection, through the design and implementation of new assays and testing algorithms in the community.
Agenda Item Image
Dr. Marion Selfridge
Research Manager
Cool Aid Community Health Centre

#VP80: Reinfection Following Successful Direct-Acting Antiviral Therapy For HCV Infection Among People Attending An Inner-City Community Health Centre In Victoria, Canada

Abstract PDF

Speaker Presentation

Video / Audio Recordings

Biography

Marion Selfridge is a research coordinator, focusing on HIV and Hepatitis C treatment at the Cool Aid Community Health Centre and post-doctoral fellow at UVic’s CISUR. Her PhD dissertation research focused on street-involved youths’ use of social media to deal with grief and loss. She teaches dance to stay sane.
Dr Alan Yeung
Research Fellow
Glasgow Caledonian University

#VP81: Population-Level Estimates Of Detected And Undetected Hepatitis C Reinfection Following The Early Scale-Up Of HCV DAA Treatment Among People Who Inject Drugs In Scotland

Abstract PDF

Speaker Presentation

Video / Audio Recordings

Biography

Alan Yeung is a research fellow in the blood borne viruses research group at Glasgow Caledonian University and a healthcare scientist at Public Health Scotland. Alan’s research areas include hepatitis C, HIV PrEP, people who inject drugs, and novel psychoactive substances.
loading